You just read:

SELLAS Life Sciences Group and TrojanTec Sign Exclusive License Agreement for Global Rights on Development and Commercialization of Innovative TR-1 Anti-Cancer Antennapedia Technology

News provided by

SELLAS Life Sciences Group

15 Apr, 2015, 14:00 BST